Article Details

Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA ...

Retrieved on: 2022-12-13 17:52:00

Tags for this article:

Click the tags to see associated articles and topics

Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA .... View article details on HISWAI: https://investors.modernatx.com/news/news-details/2022/Moderna-and-Merck-Announce-mRNA-4157V940-an-Investigational-Personalized-mRNA-Cancer-Vaccine-in-Combination-with-KEYTRUDAR-pembrolizumab-Met-Primary-Efficacy-Endpoint-in-Phase-2b-KEYNOTE-942-Trial/default.aspx

Excerpt

mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a ... for an investigational mRNA cancer treatment in a randomized clinical trial.

Article found on: investors.modernatx.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up